Attendo AB is a company that is engaged in providing private care and healthcare services in the Nordics. It focuses on offering care for older people, care for people with disabilities, individual and family care, and health care. The company also offers health, medical, and as well as staffing services. Geographically, the group's majority revenue is generated from Finland.
1985
35.0K+
LTM Revenue $2.0B
LTM EBITDA $366M
$2.6B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Attendo has a last 12-month revenue (LTM) of $2.0B and a last 12-month EBITDA of $366M.
In the most recent fiscal year, Attendo achieved revenue of $2.0B and an EBITDA of $355M.
Attendo expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Attendo valuation multiples based on analyst estimatesLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue | $2.0B | XXX | $2.0B | XXX | XXX | XXX |
Gross Profit | $2.0B | XXX | $846M | XXX | XXX | XXX |
Gross Margin | 100% | XXX | 43% | XXX | XXX | XXX |
EBITDA | $366M | XXX | $355M | XXX | XXX | XXX |
EBITDA Margin | 19% | XXX | 18% | XXX | XXX | XXX |
EBIT | $154M | XXX | $145M | XXX | XXX | XXX |
EBIT Margin | 8% | XXX | 7% | XXX | XXX | XXX |
Net Profit | $53.7M | XXX | $46.4M | XXX | XXX | XXX |
Net Margin | 3% | XXX | 2% | XXX | XXX | XXX |
Net Debt | XXX | XXX | $210M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Attendo's stock price is SEK 62 (or $6).
Attendo has current market cap of SEK 9.2B (or $950M), and EV of SEK 25.4B (or $2.6B).
See Attendo trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$2.6B | $950M | XXX | XXX | XXX | XXX | $0.42 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Attendo has market cap of $950M and EV of $2.6B.
Attendo's trades at 1.3x EV/Revenue multiple, and 7.4x EV/EBITDA.
Equity research analysts estimate Attendo's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Attendo has a P/E ratio of 17.7x.
See valuation multiples for Attendo and 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Market cap (current) | $950M | XXX | $950M | XXX | XXX | XXX |
EV (current) | $2.6B | XXX | $2.6B | XXX | XXX | XXX |
EV/Revenue | 1.3x | XXX | 1.3x | XXX | XXX | XXX |
EV/EBITDA | 7.2x | XXX | 7.4x | XXX | XXX | XXX |
EV/EBIT | 17.0x | XXX | 18.1x | XXX | XXX | XXX |
EV/Gross Profit | 1.3x | XXX | n/a | XXX | XXX | XXX |
P/E | 17.7x | XXX | 20.5x | XXX | XXX | XXX |
EV/FCF | 15.1x | XXX | 11.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialAttendo's last 12 month revenue growth is 1%
Attendo's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $20K for the same period.
Attendo's rule of 40 is 19% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Attendo's rule of X is 21% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Attendo and other 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue Growth | 1% | XXX | 1% | XXX | XXX | XXX |
EBITDA Margin | 19% | XXX | 18% | XXX | XXX | XXX |
EBITDA Growth | 5% | XXX | 10% | XXX | XXX | XXX |
Rule of 40 | 19% | XXX | 19% | XXX | XXX | XXX |
Bessemer Rule of X | XXX | XXX | 21% | XXX | XXX | XXX |
Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
Opex per Employee | XXX | XXX | $20K | XXX | XXX | XXX |
S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
Opex to Revenue | XXX | XXX | 36% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
National Healthcare Corp | XXX | XXX | XXX | XXX | XXX | XXX |
Regis Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
Maternus-Kliniken | XXX | XXX | XXX | XXX | XXX | XXX |
Addus HomeCare | XXX | XXX | XXX | XXX | XXX | XXX |
Amedisys | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Attendo acquired XXX companies to date.
Last acquisition by Attendo was XXXXXXXX, XXXXX XXXXX XXXXXX . Attendo acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free TrialWhen was Attendo founded? | Attendo was founded in 1985. |
Where is Attendo headquartered? | Attendo is headquartered in Sweden. |
How many employees does Attendo have? | As of today, Attendo has 35.0K+ employees. |
Who is the CEO of Attendo? | Attendo's CEO is Mr. Martin Tiveus. |
Is Attendo publicy listed? | Yes, Attendo is a public company listed on STO. |
What is the stock symbol of Attendo? | Attendo trades under ATT ticker. |
When did Attendo go public? | Attendo went public in 2015. |
Who are competitors of Attendo? | Similar companies to Attendo include e.g. National Healthcare Corp, Regis Healthcare, Maternus-Kliniken, Addus HomeCare. |
What is the current market cap of Attendo? | Attendo's current market cap is $950M |
What is the current revenue of Attendo? | Attendo's last 12 months revenue is $2.0B. |
What is the current revenue growth of Attendo? | Attendo revenue growth (NTM/LTM) is 1%. |
What is the current EV/Revenue multiple of Attendo? | Current revenue multiple of Attendo is 1.3x. |
Is Attendo profitable? | Yes, Attendo is EBITDA-positive (as of the last 12 months). |
What is the current EBITDA of Attendo? | Attendo's last 12 months EBITDA is $366M. |
What is Attendo's EBITDA margin? | Attendo's last 12 months EBITDA margin is 19%. |
What is the current EV/EBITDA multiple of Attendo? | Current EBITDA multiple of Attendo is 7.2x. |
What is the current FCF of Attendo? | Attendo's last 12 months FCF is $173M. |
What is Attendo's FCF margin? | Attendo's last 12 months FCF margin is 9%. |
What is the current EV/FCF multiple of Attendo? | Current FCF multiple of Attendo is 15.1x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.